AFFERA, INC.

affera-inc-logo

Affera is a medical technology company dedicated to developing innovative solutions for the treatment of cardiac arrhythmia, a prevalent condition affecting millions of patients worldwide.

#SimilarOrganizations #People #Financial #Website #More

AFFERA, INC.

Social Links:

Industry:
Biotechnology Health Care

Founded:
2015-01-01

Address:
Watertown, Massachusetts, United States

Country:
United States

Website Url:
http://www.affera.com

Total Employee:
11+

Status:
Active

Contact:
+1 857-304-4030

Email Addresses:
[email protected]

Total Funding:
5 M USD

Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Apple Mobile Web Clips Icon Google Font API Google Tag Manager WordPress Google Analytics Global Site Tag Mobile Non Scaleable Content HSTS


Similar Organizations

aer-therapeutics-logo

Aer Therapeutics

Aer Therapeutics, a clinical-stage biopharmaceutical company developing therapeutic solutions for muco-obstructive lung diseases.

cognito-therapeutics-logo

Cognito Therapeutics

Cognito Therapeutics is a focused on discovering and developing new Alzheimer's treatments and preventive therapies.

eureka-therapeutics-logo

Eureka Therapeutics

Eureka Therapeutics is a biotechnology company focusing on immunotherapies for the treatment of cancer.

eden-biologics-logo

Eden Biologics

Eden Biologics is a biopharmaceutical company that develops biosimilars and accelerates the development programs for clients & partners.

mirvie-logo

Mirvie

Mirvie is a biotech company that creates precise, actionable, and non-invasive tests for maternal-fetal health.

semma-therapeutics-logo

Semma Therapeutics

Semma Therapeutics was founded to develop transformative therapies for Type 1 diabetes patients.

stratus-medical-logo

Stratus Medical

Stratusยฎ Medical's mission is to improve clinical outcomes for chronic pain patients by advancing RF technology for the treatment of pain.

tmunity-therapeutics-logo

Tmunity Therapeutics

Tmunity Therapeutics is developing novel products to unleash the immunological potential of T cells

tridiuum-logo

Tridiuum

Tridiuum is a digital health company that is advancing the treatment of behavioral health conditions.

walden-biosciences-logo

Walden Biosciences

Walden Biosciences is a biotechnology company focused on transforming the treatment of kidney disease.


Current Advisors List

leon-amariglio_image

Leon Amariglio Board Member @ Affera, Inc.
Board_member
2014-12-01

Current Employees Featured

doron-harlev_image

Doron Harlev
Doron Harlev Founder and CEO @ Affera, Inc.
Founder and CEO
2014-03-01

not_available_image

Bob Mest
Bob Mest Product Development Consultant @ Affera, Inc.
Product Development Consultant
2016-10-01

Founder


doron-harlev_image

Doron Harlev

Investors List

innogest-sgr_image

Innogest Capital

Innogest Capital investment in Venture Round - Affera, Inc.

norwich-ventures_image

Norwich Ventures

Norwich Ventures investment in Series A - Affera, Inc.

betaangels-management_image

BAMCAP

BAMCAP investment in Series A - Affera, Inc.

Official Site Inspections

http://www.affera.com Semrush global rank: 8.4 M Semrush visits lastest month: 537

  • Host name: 180.241.167.72.host.secureserver.net
  • IP address: 72.167.241.180
  • Location: Scottsdale United States
  • Latitude: 33.6013
  • Longitude: -111.8867
  • Metro Code: 753
  • Timezone: America/Phoenix
  • Postal: 85260

Loading ...

More informations about "Affera, Inc."

Affera, Inc. โ€“ Innovative Solutions for the Treatment of Cardiac โ€ฆ

Apr 24, 2023 Doron is the founder and CEO of Affera, Inc. Prior to Affera, Doron co-founded and served as co-CEO at Rhythmia Medical, which developed a unique Electroanatomical Mapping System for the treatment of Cardiac Arrhythmia. Acquired by Boston Scientific in 2012, Rhythmia became Boston Scientificโ€™s cardiac mapping and navigation division, where ...See details»

Affera, Inc. Management Team | Org Chart - RocketReach

Affera, Inc. employs 13 employees. The Affera, Inc. management team includes Victoria Low (Senior Manager, Clinical Program Management), and Paul Hultz (Senior Engineering โ€ฆSee details»

Affera, Inc. - Crunchbase Company Profile & Funding

Affera, Inc. may be growing as it has been acquired by a larger company, which typically indicates a positive valuation and a strategic fit for the acquirer's portfolio. The acquisition is aimed at expanding the acquirer's cardiac ablation portfolio, suggesting that Affera's offerings are valuable and complementary to existing products in the market.See details»

Medtronic to Acquire Affera - Newswire

Jan 10, 2022 "Bringing Affera into our organization, with our established footprint in the cardiac ablation space, will strengthen our ability to provide innovative therapies and enable Medtronic โ€ฆSee details»

Medtronic completes acquisition of Affera | Markets Insider

Aug 30, 2022 Affera is a medical technology company dedicated to delivering unrivaled innovative solutions to address the rapidly growing demands for cardiac arrhythmia treatment. โ€ฆSee details»

Affera 2025 Company Profile: Valuation, Investors, Acquisition

Affera General Information Description. Developer of a medical device designed to treat heart rhythm disorders. The company is engaged in the design and development of a novel medical system for the treatment of heart rhythm disorders, enabling healthcare institutions to address the unmet needs in cardiac arrhythmia treatment.See details»

Affera, Inc. Company Profile | Newtonville, MA | Competitors ...

Find company research, competitor information, contact details & financial data for Affera, Inc. of Newtonville, MA. Get the latest business insights from Dun & Bradstreet.See details»

Medtronic acquires Affera, Inc. - 2022-01-10 - Crunchbase

Affera, Inc. Affera is a medical technology company dedicated to developing innovative solutions for the treatment of cardiac arrhythmia. Acquiring Organization: Medtronic Medtronic is a โ€ฆSee details»

Medtronic to Buy Affera for Nearly $1B | Twin Cities โ€ฆ

Jan 11, 2022 Citing analysts at Minneapolis-based investment firm Piper Sandler, the Star Tribune reported that the transaction will cost Medtronic $925 million. โ€œBringing Affera into our organization, with ...See details»

Affera, Inc. - Funding, Financials, Valuation & Investors - Crunchbase

Affera is a medical technology company dedicated to developing innovative solutions for the treatment of cardiac arrhythmia. New. Resources. Advanced Search. ... How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Jan 1, 2021: Venture Round ...See details»

Affera - Products, Competitors, Financials, Employees, โ€ฆ

Affera is a medical technology company that designs and manufactures cardiac mapping and navigation systems, catheter-based cardiac ablation technologies, and focal pulsed field โ€ฆSee details»

Affera, Inc. - Contacts, Employees, Board Members ... - Crunchbase

Affera is a medical technology company dedicated to developing innovative solutions for the treatment of cardiac arrhythmia. ... Experience the new Crunchbase, powered by AI . Experience the new Crunchbase, powered by AI . Organization. Affera, Inc. Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar ...See details»

Affera Company Profile - Office Locations, Competitors, Revenue โ€ฆ

Affera has 5 employees across 2 locations. See insights on Affera including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»

Affera - Ownership and Business Overview - Mergr

Affera is a medical technology company dedicated to delivering unrivaled innovative solutions to address the rapidly growing demands for cardiac arrhythmia treatment. Affera is developing a โ€ฆSee details»

Medtronic to Acquire Affera for Undisclosed Amount

Jan 10, 2022 โ€œThe EP [electrophysiology] ablation market is an exciting and fast-moving segment of cardiology. Bringing Affera into our organization, with our established footprint in โ€ฆSee details»

Medtronic acquires Affera - Today's Medical Developments

Jan 16, 2022 โ€œBringing Affera into our organization, with our established footprint in the cardiac ablation space, will strengthen our ability to provide innovative therapies and enable Medtronic entry into additional EP technology segments, such as mapping and navigation, for the first time.โ€ ... Afferaโ€™s product portfolio is not currently approved ...See details»

Medtronic to Acquire Affera - Jan 10, 2022

Jan 10, 2022 "Bringing Affera into our organization, with our established footprint in the cardiac ablation space, will strengthen our ability to provide innovative therapies and enable Medtronic โ€ฆSee details»

Medtronic completes acquisition of Affera - Newswire

Aug 30, 2022 In December 2021, Affera announced the commencement of the recently approved SPHERE Per-AF Trial, a U.S. Food and Drug Administration Investigational Device โ€ฆSee details»

Medtronic Acquires Affera to Add Mapping and Navigation โ€ฆ

Sep 2, 2022 Following the announcement of Medtronic's acquisition of Affera, here Rebecca Seidel, President, Cardiac Ablation Solutions, Medtronic discusses the burden presented by โ€ฆSee details»

Medtronic Announces Aquisition of Affera - Surgical Robotics โ€ฆ

Medtronic has announced that it has entered into a definitive agreement to acquire Affera, Inc., a Boston area-based, privately held medical technology company.Affera designs and manufactures cardiac mapping and navigation systems and catheter-based cardiac ablation technologies, including a differentiated, focal pulsed field ablation solution, for the treatment of patients with โ€ฆSee details»

linkstock.net © 2022. All rights reserved